| Stage | CBZ | % of rev | EEFT | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $702M | 100.00% | $1.1B | 100.00% | EEFT ×1.58 |
| Gross profit | $114M | 16.24% | $915M | 82.56% | EEFT +66.3pp |
| Operating income | $76M | 10.76% | $137M | 12.37% | EEFT +1.6pp |
| Pre-tax income | $53M | 7.55% | $124M | 11.21% | EEFT +3.7pp |
| Net income | $37M | 5.24% | $78M | 7.00% | EEFT +1.8pp |
| Stage | CBZ | EEFT | Gap · A − B |
|---|---|---|---|
| Revenue | $702M100.00% | $1.1B100.00% | EEFT ×1.58 |
| Gross profit | 16.24%$114M | 82.56%$915M | EEFT +66.3pp |
| Operating income | 10.76%$76M | 12.37%$137M | EEFT +1.6pp |
| Pre-tax income | 7.55%$53M | 11.21%$124M | EEFT +3.7pp |
| Net income | 5.24%$37M | 7.00%$78M | EEFT +1.8pp |
No shared counterparties.